Frameshift Genomics has recently been awarded two grants from the NHGRI, a phase I STTR and a phase I SBIR. In collaboration with the Marth Lab at the University of Utah, these grants aim to improve the IOBIO real-time genomic visualization and analysis project. Rapid and easy determination of genomic data quality problems is still challenging. Supported by one […]

• Key advances in the pharmaceutical pipeline deliver initial sales • Life Science expected to keep growing faster than the market • Performance Materials benefiting from a diversified business model • Deleveraging continues to have high priority • Active portfolio management remains a central element of the company strategy Darmstadt, Germany – Merck KGaA, Darmstadt, […]

Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells. “We are thrilled to have BORN2GROW on-board as a new investor, and that we will be able to […]

Chelmsford, Mass. — BioStorage® Technologies GMBH, the EU Biobanking and Sample Bioprocessing Services subsidiary of Brooks Life Science Systems, announced it has been awarded CIR (Credit d´Impôt Recherche) Research Tax Credit service provider status by the French Ministry of Higher Education and Research (MESR), for the three-year period 2017 through 2019. The CIR allows eligible research-based […]

LAUSANNE, Switzerland SOPHiA GENETICS, the global leader in Data-Driven Medicine that has created SOPHiA Artificial Intelligence, today announced the close of a $30 million Series D funding round. The round was led by London-based Balderton Capital joined by 360º Capital Partners alongside existing investors British tech star Mike Lynch’s Invoke Capital and Alychlo, the investment firm of Belgian pharmaceutical entrepreneur Marc Coucke. […]

MEDFORD, Mass. — GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round, along with the majority of GreenLight’s existing investors, including Kodiak Venture Partners, MLSCF, Syngenta Ventures and others.  GreenLight is harnessing its […]

Grant funds the commercialization of a specialized Sydor Spectro CCD detector, designed for Soft X-ray Spectrometers Rochester, NY Sydor Instruments, a Sydor Technologies Company, announced today that it has been awarded a $991,741 SBIR Phase IIA grant from the Department of Energy, Office of Science to commercialize the unique Sydor Spectro CCD. Sydor Instruments will […]

PARIS—-Synthetic DNA manufacturer DNA Script has today announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures with additional investments from M Ventures, the corporate venture arm of Merck KGaA, Darmstadt, Germany, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. DNA Script is an industry leader in the […]

Seattle, WA – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners.  The Company will also expand its regulatory infrastructure and research and development efforts.  The $30M investment was led by 5AM Ventures with participation from […]

Notable private equity firm invests £2.5 million in the Cambridge-based biotech Private equity firm Calculus Capital, a leading EIS and VCT investor, has further expanded its life science portfolio, by investing £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies the world’s top […]